HKG: 2162

Jenscare's JensClip Wins NMPA Registration Approval – Self‑Locking Transcatheter Mitral Valve Repair Clip Enters the Chinese Market
CompanyMedical Device

Jenscare’s JensClip Wins NMPA Registration Approval – Self‑Locking Transcatheter Mitral Valve Repair Clip Enters the Chinese Market

Jenscare Scientific Co., Ltd. (HKG: 9877) announced that its proprietary JensClip Transcatheter Mitral Valve Repair Clip System ("JensClip") has received registration approval from China's National Medical Products Administration (NMPA). The…

Roche Reports Positive Phase II Topline Data for Enicepatide – Once‑Weekly GLP‑1/GIP Agonist Cuts HbA1c by 2.65% and Body Weight by 15.5% at 48 Weeks

Roche Reports Positive Phase II Topline Data for Enicepatide – Once‑Weekly GLP‑1/GIP Agonist Cuts HbA1c by 2.65% and Body Weight by 15.5% at 48 Weeks

BMS Plans 265 Princeton Layoffs – Bristol Myers Squibb Extends Its USD 2 Billion Cost Cutting Drive

BMS Plans 265 Princeton Layoffs – Bristol-Myers Squibb Extends Its USD 2 Billion Cost Cutting Drive

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Ouro Medicines Launches with $120M Series A Financing for CM336 Development
CompanyDeals

Ouro Medicines Launches with $120M Series A Financing for CM336 Development

Keymed Biosciences Licenses CM313 to Timberlyne Therapeutics for Global Development
CompanyDeals

Keymed Biosciences Licenses CM313 to Timberlyne Therapeutics for Global Development

Keymed Biosciences' Kangyueda Approved for CRSwNP Treatment in China
CompanyDrug

Keymed Biosciences’ Kangyueda Approved for CRSwNP Treatment in China

Keymed Biosciences Presents CM336 Data for Relapsed Multiple Myeloma at ASH Annual Meeting
CompanyDrug

Keymed Biosciences Presents CM336 Data for Relapsed Multiple Myeloma at ASH Annual Meeting

Jiangsu Hengrui Medicine's SHR-1819 Receives NMPA Approval for Atopic Dermatitis Clinical Trial
CompanyDrug

Jiangsu Hengrui Medicine’s SHR-1819 Receives NMPA Approval for Atopic Dermatitis Clinical Trial

Keymed Biosciences Enters Global Licensing Agreement with Platina Medicines for CM336
CompanyDeals

Keymed Biosciences Enters Global Licensing Agreement with Platina Medicines for CM336

CompanyDrug

Keymed Biosciences’ Stapokibart Receives First Prescription in China for IL-4Rα Targeting Therapy

CompanyDrug

Keymed Biosciences’ IL-4Rα mAb Stapokibart Receives NMPA Approval for Atopic Dermatitis Treatment

Show More